Press "Enter" to skip to content

With Stringent Oversight, Heritable Human Genome Editing Could Be Allowed for Serious Conditions

Clinical trials for genome editing of the human germline – adding, removing, or replacing DNA base pairs in gametes or early embryos – could be permitted in the future, but only for serious conditions under stringent oversight, says a new report from the National Academy of Sciences and the National Academy of Medicine.

Be First to Comment

Leave a Reply